Status:
UNKNOWN
ANalyzing Olfactory Dysfunction Mechanisms In COVID-19
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
Max Planck Research Unit for Neurogenetics
AZ Sint-Lucas Brugge
Conditions:
SARS-CoV-2
Eligibility:
All Genders
Phase:
NA
Brief Summary
We aim to understand the mechanism of olfactory dysfunction in COVID-19.
Detailed Description
In December 2019, a new coronavirus causing severe acute respiratory syndrome was described in Wuhan, China. This virus, later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), sprea...
Eligibility Criteria
Inclusion
- \- Deceased hospitalised patients, tested positive or negative for SARS-CoV-2 for patient or control group respectively
Exclusion
- none
Key Trial Info
Start Date :
May 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04445597
Start Date
May 7 2020
End Date
December 31 2024
Last Update
May 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000